1. Introduction

Cross-Border Reproductive Services Regulation refers to the legal framework governing reproductive medical treatments and services obtained by individuals or couples in a country other than their country of residence, nationality or permanent domicile.

It is an important area of international biotechnology law, reproductive rights, medical law, private international law, human rights law and public health regulation.

The growth of reproductive technologies has enabled individuals to travel internationally for treatments that may be prohibited, unavailable, expensive or subject to restrictive conditions in their home countries.

Cross-border reproductive services may include:

In-vitro fertilisation (IVF).

Intracytoplasmic sperm injection (ICSI).

Surrogacy arrangements.

Egg and sperm donation.

Embryo donation and transfer.

Preimplantation genetic testing (PGT).

Fertility preservation and gamete storage.

Mitochondrial replacement techniques.

Reproductive genetic testing.

Cross-border reproductive tissue transportation.

Fertility treatment involving foreign donors.

Posthumous reproduction using stored gametes or embryos.

The central legal problem arises when the country providing reproductive services applies different rules from the country where the intended parents live or where the resulting child will acquire nationality and legal parentage.

For example, a couple may obtain IVF treatment in one country, use donor eggs from another country, create embryos in a third country and subsequently seek recognition of parentage in their home country.

This creates questions concerning reproductive autonomy, consent, medical negligence, parentage, citizenship, child welfare, commercial exploitation, data protection and enforcement of foreign judgments.

The fundamental regulatory challenge is to reconcile reproductive freedom with public policy, medical safety, ethical standards and the legal protection of children born through assisted reproductive technologies.

2. Meaning and Scope of Cross-Border Reproductive Services

Cross-border reproductive services involve reproductive healthcare transactions or arrangements having a substantial connection with more than one country.

Three principal elements generally arise:

Medical element: Reproductive treatment is performed by a foreign fertility clinic, hospital, laboratory or medical practitioner.

Contractual element: Intended parents, donors, surrogates, agencies and clinics may be governed by different national legal systems.

Family-law element: The resulting child's parentage, nationality, inheritance rights and legal identity may require recognition in another country.

Important forms of cross-border reproductive services

3. International Legal Framework

There is no single comprehensive international treaty that harmonises all cross-border reproductive services. Regulation is fragmented across human rights instruments, medical standards, child-protection conventions and national assisted-reproduction legislation.

A. International human rights instruments

1. Universal Declaration of Human Rights, 1948

Article 16 recognises the right to marry and found a family. It provides an important human-rights foundation for reproductive autonomy, although it does not establish an unrestricted right to access every reproductive technology.

2. International Covenant on Civil and Political Rights, 1966

Relevant provisions include:

Article 17: Protection against arbitrary interference with privacy and family life.

Article 23: Protection of family life and the right to marry and found a family.

Article 24: Special protection of children.

These provisions are relevant when reproductive treatment, donor identity or parentage decisions interfere with private and family life.

3. International Covenant on Economic, Social and Cultural Rights, 1966

Article 12 recognises the right to the highest attainable standard of physical and mental health.

It supports consideration of access to reproductive healthcare, including appropriate medical services, without establishing an unlimited obligation to provide every form of fertility treatment.

4. Convention on the Rights of the Child, 1989

Important provisions include:

Article 3: Best interests of the child.

Article 7: Right to birth registration, a name and, as far as possible, knowledge of parents.

Article 8: Preservation of identity.

Article 9: Protection of family relationships.

These provisions are particularly significant where a child is born through international surrogacy or donor-assisted reproduction.

B. European human rights framework

The European Convention on Human Rights is particularly important in reproductive disputes.

Article 8 protects private and family life.

Article 14 prohibits discrimination in the enjoyment of Convention rights.

Article 12 protects the right to marry and found a family.

The European Court of Human Rights has developed substantial jurisprudence concerning reproductive autonomy, access to reproductive technologies, embryo rights and recognition of parentage.

C. Hague Conference instruments

The Hague Conference on Private International Law has examined the private international law problems created by parentage and international surrogacy.

Its work on parentage and surrogacy includes questions concerning:

Recognition of foreign parentage.

Jurisdiction over parentage disputes.

Applicable law.

Recognition of foreign birth certificates and judgments.

Protection of children born through international arrangements.

The 1993 Hague Adoption Convention may be relevant where an arrangement is legally classified as an adoption, but surrogacy is not automatically equivalent to adoption.

The Hague Parentage/Surrogacy Project has explored possible international solutions; it should not be confused with an already operative universal surrogacy-recognition treaty.

4. Major Legal Issues in Cross-Border Reproductive Services

A. Jurisdiction and applicable law

Jurisdiction determines which country's courts and regulatory authorities can decide disputes involving reproductive treatment.

A cross-border reproductive arrangement may involve:

The country where the fertility clinic operates.

The country where the intended parents reside.

The country where the surrogate mother resides.

The country where the child is born.

The country where parentage or citizenship recognition is sought.

The applicable law may differ for medical negligence, contractual liability, consent, parentage and citizenship.

Example: If an Indian couple obtains IVF treatment in another country and subsequently brings the child to India, questions may arise concerning the validity of the foreign treatment, recognition of parentage and compliance with Indian immigration and family-law requirements.

Courts may consider territorial jurisdiction, habitual residence, domicile, nationality, the place of performance of the contract and the child's best interests.

B. Recognition of foreign parentage

One of the most difficult legal questions concerns whether the country of residence must recognise parentage established abroad.

For example, a foreign birth certificate may identify two intended parents as the child's legal parents, while domestic law may apply different parentage rules.

The legal issues include:

Whether a foreign birth certificate is conclusive evidence of parentage.

Whether a foreign court judgment must be recognised.

Whether the surrogate mother retains legal parental status.

Whether genetic connection is necessary.

Whether the child's best interests justify recognition.

Whether public policy permits refusal of recognition.

Recognition of parentage is not necessarily the same as recognition of a foreign surrogacy contract.

C. Commercial exploitation and reproductive tourism

Some countries prohibit commercial surrogacy, while others permit regulated compensation.

This difference may encourage reproductive tourism.

The legal concerns include:

Economic exploitation of surrogate mothers.

Unequal bargaining power.

Unregulated reproductive agencies.

Coercive contractual conditions.

Inadequate insurance.

Medical complications.

Refusal to accept children with disabilities.

Disputes concerning multiple births.

Abandonment of children.

Trafficking and illegal payments.

International regulation must distinguish legitimate reproductive healthcare from exploitation and unlawful commercialisation.

D. Informed consent and reproductive autonomy

Informed consent is essential at every stage of reproductive treatment.

A fertility clinic must explain:

Medical risks and treatment alternatives.

Embryo creation and storage.

Genetic testing procedures.

Donor-related legal consequences.

Embryo disposal and transfer.

Withdrawal of consent.

Risks of multiple pregnancy.

Financial obligations.

Confidentiality and data-sharing arrangements.

A foreign consent form does not automatically resolve every dispute in the patient's home country.

The validity of consent may depend on applicable national law, the patient's capacity, the information provided and the circumstances in which consent was obtained.

E. Donor anonymity and genetic identity

Cross-border gamete donation creates conflicts between:

Donor privacy.

The child's interest in genetic identity.

The intended parents' privacy.

Medical confidentiality.

The child's right to obtain relevant genetic and medical information.

A donor who is legally anonymous in one country may be identifiable under the law of another country.

This creates problems where donor records are transferred internationally or a child later seeks information about genetic origins.

F. Embryo transportation and cryopreservation

International transportation of frozen embryos, sperm and eggs raises questions concerning:

Import and export permissions.

Laboratory accreditation.

Biological safety.

Storage conditions.

Chain of custody.

Identity verification.

Consent of gamete providers.

Embryo ownership and disposition.

Transport-related damage.

Insurance and compensation.

A country may permit embryo storage but prohibit certain uses, such as sex selection or particular genetic procedures.

G. Medical negligence and liability

Cross-border reproductive treatment can create complicated liability disputes.

Potential defendants include:

Fertility clinics.

Reproductive specialists.

Embryologists.

Genetic laboratories.

Donor banks.

International agencies.

Transportation companies.

Insurance providers.

A patient may have to pursue litigation in a foreign jurisdiction even though the injury becomes apparent after returning home.

Questions include the applicable standard of care, limitation periods, expert evidence, jurisdiction clauses and enforcement of foreign judgments.

H. Citizenship and immigration

Children born through international reproductive arrangements may face difficulties in obtaining:

Birth registration.

Passports.

Citizenship.

Immigration documents.

Recognition of legal parents.

Travel permissions.

A child may be recognised as a citizen in the country of birth but encounter difficulties obtaining nationality through the intended parents.

This is especially problematic when the country of birth recognises a surrogacy arrangement but the intended parents' country refuses to recognise its parentage consequences.

5. Important Case Laws and Judicial Decisions

The following cases provide important principles for understanding reproductive autonomy, international surrogacy, parentage, embryo rights and cross-border reproductive treatment.

1. Mennesson v. France (2014)

Citation: Application No. 65192/11, European Court of Human Rights, 26 June 2014.

Facts:

A French couple entered into a gestational surrogacy arrangement in the United States. Twins were born in California, and the American authorities recognised the intended parents under the applicable legal arrangements.

French authorities refused to recognise the children's legal parentage because commercial surrogacy arrangements conflicted with French public policy.

Legal issues:

Recognition of foreign parentage.

International surrogacy.

Children's private and family life.

Public policy limitations.

Judgment:

The European Court of Human Rights held that France's refusal to recognise the parent-child relationship violated Article 8 of the European Convention on Human Rights in respect of the children's right to respect for private life.

The Court emphasised the importance of the children's legal identity and their relationship with their intended parents, particularly their biological father.

Legal principle:

A state cannot disregard the serious consequences for a child's identity merely because the reproductive arrangement was legally established abroad.

Importance:

This is a foundational decision concerning recognition of parentage arising from international surrogacy.

2. Labassee v. France (2014)

Citation: Application No. 65941/11, European Court of Human Rights, 26 June 2014.

Facts:

A French couple entered into a surrogacy arrangement in the United States. A child was born through the arrangement, but French authorities refused to recognise the foreign parentage.

Judgment:

The European Court found a violation of Article 8 concerning the child's right to respect for private life.

Legal principle:

The child's legal identity and personal status cannot be disregarded solely because the underlying reproductive arrangement conflicts with domestic public policy.

Importance:

The case reinforces the distinction between a state's ability to prohibit surrogacy domestically and its obligation to protect children born through foreign reproductive arrangements.

3. Paradiso and Campanelli v. Italy (2017)

Citation: Application No. 25358/12, Grand Chamber, European Court of Human Rights, 24 January 2017.

Facts:

An Italian couple obtained a child through a surrogacy arrangement in Russia. The child had no biological relationship with either intended parent.

Italian authorities removed the child and refused to recognise the intended parental relationship.

Legal issue:

Whether the removal of the child violated the intended parents' right to respect for family life under Article 8.

Judgment:

The Grand Chamber held that there had been no violation of Article 8.

The Court considered the absence of biological ties, the short duration of the relationship and the absence of legally established family life.

Legal principle:

Recognition of foreign reproductive arrangements is not automatic. The Court must examine the actual circumstances, including biological connections, the existence of family life and the child's interests.

Importance:

This decision demonstrates that the protection given in Mennesson does not create an unconditional right to recognition of every foreign surrogacy arrangement.

4. Advisory Opinion concerning the recognition in domestic law of a legal parent-child relationship between a child born through a gestational surrogacy arrangement abroad and the intended mother (2019)

Citation: European Court of Human Rights, Grand Chamber, Advisory Opinion, 10 April 2019, Request No. P16-2018-001.

Facts:

The French authorities sought clarification concerning recognition of the legal relationship between a child born through international gestational surrogacy and the intended mother.

The intended mother had no biological connection with the child.

Opinion:

The Court stated that Article 8 requires domestic law to provide a possibility of recognising the legal parent-child relationship with the intended mother, where the relationship has been legally established abroad and recognition is necessary to protect the child's rights.

However, the Convention does not require recognition to take the form of direct transcription of the foreign birth certificate. Adoption may be an acceptable alternative, provided the procedure is sufficiently prompt and effective.

Legal principle:

A state retains some discretion regarding the method of recognition, but it must provide an effective mechanism protecting the child's legal identity.

Importance:

This advisory opinion is particularly important for international parentage recognition and the development of cross-border family law.

5. S.H. and Others v. Austria (2011)

Citation: Application No. 57813/00, Grand Chamber, European Court of Human Rights, 3 November 2011.

Facts:

Two Austrian couples challenged restrictions on the use of donor eggs and donor sperm in assisted reproductive treatment.

Austrian legislation prohibited certain forms of heterologous artificial reproduction.

Legal issue:

Whether restrictions on access to reproductive technologies violated Article 8 and Article 14 of the European Convention on Human Rights.

Judgment:

The Grand Chamber recognised that the right of a couple to conceive a child and use medically assisted procreation falls within the protection of private and family life under Article 8.

However, it found no violation in the circumstances, giving the state a margin of appreciation in regulating ethically sensitive reproductive technologies.

Legal principle:

States may regulate reproductive technologies, but restrictions must be assessed against privacy, equality, medical developments and proportionality.

Importance:

The case is relevant to cross-border fertility treatment because differing national rules may encourage patients to travel abroad to access reproductive procedures unavailable at home.

6. Evans v. United Kingdom (2007)

Citation: Application No. 6339/05, Grand Chamber, European Court of Human Rights, 10 April 2007.

Facts:

A woman underwent IVF treatment with her former partner. Embryos were created and frozen. Following the breakdown of their relationship, the man withdrew his consent to the embryos being used.

The woman challenged the legal requirement for continued consent.

Legal issue:

Whether the withdrawal of consent violated the woman's right to respect for private life under Article 8.

Judgment:

The Grand Chamber found no violation of Article 8.

It upheld the importance of the requirement that both genetic contributors consent to embryo implantation under the applicable legislation.

Legal principle:

The right to reproductive autonomy must be balanced against the right of another genetic contributor not to become a parent without consent.

Importance:

The judgment is relevant to international embryo transportation and storage disputes, especially when one party withdraws consent after embryos have been transferred to another jurisdiction.

7. Dickson v. United Kingdom (2007)

Citation: Application No. 44362/04, Grand Chamber, European Court of Human Rights, 4 December 2007.

Facts:

A prisoner and his wife sought access to artificial insemination facilities so that they could have a child despite his imprisonment.

The authorities refused their request.

Judgment:

The Court found a violation of Article 8.

Legal principle:

The right to respect for private and family life includes important decisions concerning genetic parenthood.

Importance:

The case establishes that reproductive autonomy is a protected human-rights interest, although it does not create an absolute entitlement to every reproductive service.

8. Baby Manji Yamada v. Union of India (2008)

Citation: (2008) 13 SCC 518, Supreme Court of India.

Facts:

A Japanese couple entered into a surrogacy arrangement in India. A child, Manji, was born through the arrangement.

Before the child's birth, the intended parents separated. The resulting circumstances created uncertainty concerning the child's custody, nationality and travel documents.

The child was genetically related to the intended father.

Legal issues:

International surrogacy.

Nationality and travel documentation.

Custody and legal identity.

Recognition of reproductive arrangements.

Protection of a child born through surrogacy.

Judgment:

The Supreme Court considered the circumstances and disposed of the proceedings, enabling the child to receive appropriate care and documentation.

The Court recognised that commercial surrogacy was not prohibited under the legal position prevailing in India at that time.

Legal principle:

Children born through reproductive arrangements must not be left without protection because of disputes between intended parents or uncertainty surrounding surrogacy arrangements.

Importance:

This is a significant Indian case illustrating the difficulties created by international reproductive tourism.

However, its discussion of commercial surrogacy reflects the legal position before the enactment of the Surrogacy (Regulation) Act, 2021. It must not be treated as authority permitting commercial surrogacy in India today.

9. Jan Balaz v. Anand Municipality (2009)

Citation: Special Civil Application No. 3020 of 2008, Gujarat High Court, 2009.

Facts:

A German couple had twins through surrogacy in Gujarat, India.

The children were born in India, but questions arose concerning their citizenship, passports and recognition by German authorities.

The dispute highlighted the difficulties of establishing nationality and parentage where the country of birth and the intended parents' country applied different legal rules.

Legal issues:

Citizenship of children born through surrogacy.

Foreign recognition of parentage.

International travel documentation.

Legal status of intended parents.

Importance:

The litigation demonstrates that a child born through international surrogacy may encounter serious nationality and immigration complications even when the reproductive procedure itself has been completed.

It is an important illustration of the need for coordinated rules on parentage and nationality.

10. Suchita Srivastava v. Chandigarh Administration (2009)

Citation: (2009) 9 SCC 1, Supreme Court of India.

Facts:

The case concerned the reproductive autonomy of a woman with an intellectual disability and the question of whether the state could compel termination of her pregnancy.

Judgment:

The Supreme Court recognised reproductive choice as an aspect of personal liberty under Article 21 of the Constitution.

It emphasised bodily integrity, privacy and the right to make reproductive decisions.

Legal principle:

Reproductive autonomy includes the right to make decisions concerning reproduction and bodily integrity, subject to applicable legal safeguards.

Importance:

Although not a cross-border fertility case, it provides an important constitutional foundation for analysing reproductive services and reproductive consent in India.

11. K.S. Puttaswamy v. Union of India (2017)

Citation: (2017) 10 SCC 1, Supreme Court of India.

Facts:

The case concerned the constitutional status of privacy under Article 21.

Judgment:

A nine-judge Constitution Bench unanimously recognised privacy as a fundamental right.

The judgment identified privacy as encompassing bodily autonomy, decisional autonomy and intimate personal choices.

Legal principle:

Personal decisions concerning family, bodily integrity and intimate life receive constitutional protection.

Importance:

The judgment is relevant to international fertility services involving genetic information, donor identity, reproductive health records, embryo storage and cross-border transfer of personal data.

6. Indian Legal Framework Governing Cross-Border Reproductive Services

India is particularly important in this area because it was historically a destination for international surrogacy and fertility tourism.

However, the legal framework has changed substantially following the enactment of two major statutes in 2021.

A. Assisted Reproductive Technology (Regulation) Act, 2021

The Assisted Reproductive Technology (Regulation) Act, 2021 came into force on 25 January 2022.

Its principal objectives include:

Registration and regulation of ART clinics.

Regulation of ART banks.

Protection of patients and gamete donors.

Regulation of sperm and oocyte donation.

Prevention of exploitation and misuse of ART.

Ensuring safe and ethical reproductive practices.

Regulation of storage and use of gametes and embryos.

Supervision of research and development involving ART.

Important provisions

The Act creates a regulatory system involving national and state authorities and the National ART and Surrogacy Registry.

It is important for foreign patients because reproductive services conducted through Indian ART establishments must comply with Indian registration, consent and safety requirements.

Official legislation: Assisted Reproductive Technology (Regulation) Act, 2021.

India Code+1

B. Surrogacy (Regulation) Act, 2021

The Surrogacy (Regulation) Act, 2021 came into force on 25 January 2022.

It establishes a restrictive framework for surrogacy in India.

Its main objectives are:

Prohibition of commercial surrogacy.

Permitting qualifying altruistic surrogacy.

Protection of surrogate mothers.

Regulation of surrogacy clinics.

Prevention of exploitation.

Protection of children born through surrogacy.

Important provisions

Section 4 is especially important because it restricts surrogacy to specified conditions, including altruistic surrogacy and prescribed eligibility requirements.

Foreign intended parents cannot assume that they can enter India and obtain commercial surrogacy services merely because such services are available in another country.

The legislation defines eligible intended couples and intending women by reference to Indian legal requirements. It also imposes requirements concerning medical indication, certificates and the surrogate mother's eligibility.

Official legislation: Surrogacy (Regulation) Act, 2021.

India Code+1

C. Foreign nationals and reproductive tourism in India

The current Indian framework must be distinguished from the earlier commercial surrogacy regime.

The following distinctions are important:

Commercial surrogacy is prohibited.

Only arrangements satisfying statutory conditions may proceed.

Eligibility must be assessed under Indian law.

Foreign nationality or foreign residence does not automatically create eligibility.

Foreign contracts cannot override mandatory Indian legislation.

A foreign birth certificate does not automatically resolve every Indian parentage or citizenship issue.

The ART Act and Surrogacy Act regulate different but interconnected aspects of reproductive services. Compliance with one does not automatically establish compliance with the other.

D. Relevant constitutional provisions

Article 14: Equality before the law and equal protection of the laws.

Article 19: Relevant freedoms, subject to applicable constitutional restrictions.

Article 21: Protection of life and personal liberty, including privacy, dignity and reproductive autonomy.

Article 39(e) and (f): Protection of workers, children and the development of children in conditions of freedom and dignity.

Article 42: Just and humane conditions of work and maternity relief.

These constitutional provisions provide a framework for evaluating reproductive legislation, protection of surrogate mothers and children's welfare.

7. Comparative International Regulatory Approaches

Different countries adopt different regulatory approaches to assisted reproduction and surrogacy.

General election 2024 - UK Parliament

A. United Kingdom

The Human Fertilisation and Embryology Act 1990, as amended, regulates fertility treatment, embryos, gametes and licensing.

The Human Fertilisation and Embryology Authority (HFEA) supervises licensed fertility services.

The Surrogacy Arrangements Act 1985 restricts commercial surrogacy arrangements, while parental orders provide a route for transferring legal parenthood in qualifying cases.

Cross-border problems arise when foreign surrogacy arrangements do not satisfy UK parental-order requirements.

Front Steps and Facade of the U.S. Supreme Court in Washington DC

B. United States

Reproductive regulation is substantially state-based.

Some states permit compensated gestational surrogacy under statutory or judicial frameworks, while others prohibit or restrict certain arrangements.

Interstate and international disputes may concern contractual enforceability, parentage orders, citizenship and recognition of foreign judgments.

Johnson v. Calvert (1993) is an important California decision concerning competing claims to maternity in gestational surrogacy.

[어바웃 디자인] 국회의사당 디자인에 담긴 국가의 정체성

C. France

French law prohibits surrogacy arrangements under Article 16-7 of the Civil Code.

Nevertheless, the European Court of Human Rights decisions in Mennesson and Labassee demonstrate that children born through lawful foreign surrogacy arrangements have important rights concerning legal identity and parentage.

Германија може да ја издржи војната со Иран ако не трае долго | Bloomberg Adria

D. Germany

The Embryo Protection Act 1990 imposes substantial restrictions on certain reproductive procedures, including surrogacy-related conduct.

German law also raises difficult questions concerning the recognition of foreign parentage and the legal status of children born abroad.

Canberra ( Australië) | Informatie en tips - 333travel

E. Australia

Surrogacy regulation is principally state and territory based.

Commercial surrogacy is generally prohibited domestically, while altruistic surrogacy is regulated subject to jurisdiction-specific conditions.

International commercial surrogacy can also raise criminal-law, parentage and citizenship issues, depending on the applicable jurisdiction.

8. Private International Law and Conflict of Laws

Cross-border reproductive services create disputes involving different legal systems.

Four major legal doctrines are particularly relevant.

A. Lex loci actus

This principle concerns the law of the place where the relevant act or transaction occurs.

For example, the legality and professional standards of IVF treatment may be assessed under the law governing the clinic's activities.

However, compliance with the law of the treatment country does not necessarily establish recognition of parentage elsewhere.

B. Lex domicilii

This refers to the law of a person's domicile.

It may be relevant to personal status, family relationships and certain questions concerning legal capacity.

C. Habitual residence

Habitual residence is particularly significant in international family disputes.

Courts may examine:

Where the child ordinarily lives.

Where the intended parents reside.

The child's social and family environment.

The stability of the child's living arrangements.

D. Public policy exception

A country may refuse to recognise certain foreign legal arrangements if recognition would violate fundamental domestic public policy.

However, public policy cannot be applied without considering the rights and interests of the child.

The reasoning in Mennesson v. France illustrates why the interests of children may require recognition of certain parent-child relationships even when the underlying reproductive arrangement is prohibited domestically.

9. Regulatory Challenges and Emerging Legal Problems

1. Absence of international harmonisation

Countries have different rules concerning surrogacy, donor anonymity, embryo storage, genetic testing and parental status.

This creates uncertainty for intended parents and children.

2. Conflicting parental rights

A surrogate mother, intended mother and genetic mother may be different individuals.

Domestic legal systems may allocate maternity differently.

3. International enforcement of reproductive contracts

A surrogacy contract valid in one country may be unenforceable in another.

Courts must distinguish between contractual obligations and the independent legal status and welfare of the child.

4. Reproductive data protection

International fertility treatment involves sensitive information, including:

Genetic profiles.

Medical histories.

Embryo information.

Donor identities.

Reproductive health records.

Family relationships.

Cross-border data transfers may be subject to GDPR requirements in Europe, national privacy legislation and applicable Indian data-protection requirements.

5. Genetic discrimination

Genetic information obtained during fertility treatment may potentially be misused by insurers, employers or other institutions.

Legal safeguards must protect individuals against discriminatory uses of reproductive genetic information.

6. Medical tourism and accountability

Patients may have limited access to medical records or effective remedies after returning to their home countries.

International cooperation is needed for professional accountability, medical evidence and compensation.

7. Citizenship and statelessness

Conflicting nationality laws may result in children facing uncertainty concerning citizenship or travel documentation.

This requires coordination between birth registration authorities, immigration departments and family courts.

8. Commercialisation of reproductive material

International egg and sperm banks raise concerns involving payment, consent, donor screening, traceability and the commercial exploitation of human reproductive material.

9. AI-assisted reproductive services

Artificial intelligence is increasingly relevant to embryo selection, fertility prediction, sperm analysis and genetic screening.

Cross-border treatment raises questions about:

Algorithmic transparency.

Clinical responsibility.

Medical-device certification.

Reproductive discrimination.

International transfer of genomic data.

Liability for incorrect embryo assessments.

10. International regulatory cooperation

The absence of uniform standards makes cooperation between national regulators particularly important.

The Hague Conference's parentage and surrogacy project is relevant here. In March 2026, its governing body considered the Working Group's final report on the feasibility of a possible convention concerning recognition of judgments on legal parentage. It decided not to advance to a Special Commission at that stage, while allowing the issue to be revisited later.

Parentage / Surrogacy - 2011 onwards

10. Proposed Legal and Regulatory Reforms

An effective international regulatory framework should include the following safeguards.

11. Important Doctrinal Principles Emerging from Case Law

The judicial decisions discussed above establish several important legal principles.

1. Reproductive autonomy: Decisions concerning whether to have children fall within the protection of private life.

Authority: Evans v. United Kingdom; S.H. and Others v. Austria.

2. Child's legal identity: A child should not suffer disproportionate consequences because the intended parents used a reproductive arrangement abroad.

Authority: Mennesson v. France; Labassee v. France.

3. No automatic recognition: Foreign reproductive arrangements do not automatically become legally enforceable in another country.

Authority: Paradiso and Campanelli v. Italy.

4. Consent of genetic contributors: Consent to embryo implantation is a fundamental issue, and the competing interests of genetic contributors must be balanced.

Authority: Evans v. United Kingdom.

5. Protection of reproductive dignity: Reproductive decisions are closely connected with personal liberty, bodily integrity and privacy.

Authority: Suchita Srivastava v. Chandigarh Administration; K.S. Puttaswamy v. Union of India.

6. Child welfare: The legal status and welfare of children born through international reproductive arrangements must receive independent consideration.

Authority: Baby Manji Yamada v. Union of India.

12. Conclusion

Cross-Border Reproductive Services Regulation is an important developing field of international biotechnology and family law. It addresses the legal consequences of reproductive treatment undertaken across national boundaries and the resulting conflicts between different systems of medical regulation, family law, nationality law and human rights protection.

The major challenge is that reproductive services can be legally permitted in one country but prohibited or restricted in another. Such differences create disputes concerning foreign parentage, surrogacy contracts, donor anonymity, embryo ownership, medical negligence, citizenship and reproductive autonomy.

The decisions in Mennesson, Labassee, Paradiso and Campanelli, Evans, Baby Manji Yamada and Jan Balaz demonstrate that reproductive arrangements cannot be examined exclusively through contractual or domestic regulatory principles. The interests of children, intended parents, surrogate mothers and genetic contributors must also be considered.

In India, the Assisted Reproductive Technology (Regulation) Act, 2021 and the Surrogacy (Regulation) Act, 2021 provide the principal statutory framework. They have significantly changed the earlier legal environment in which international commercial surrogacy operated.

Ultimately, effective cross-border reproductive regulation requires a balance between reproductive autonomy, medical safety, informed consent, protection against exploitation, international recognition of parentage and the best interests of children.

13. Important Authorities and Further Reading

Primary legislative and institutional resources:

India – Assisted Reproductive Technology (Regulation) Act, 2021.

India – Surrogacy (Regulation) Act, 2021.

National ART and Surrogacy Portal.

European Court of Human Rights – Reproductive Rights Case-Law Factsheet.

Hague Conference – Parentage and Surrogacy Project.

Academic note: These cases arise from different jurisdictions and legal frameworks. Their holdings should be applied according to their actual legal scope; European Convention judgments are not automatically binding on Indian courts. Indian statutory provisions and subsequent amendments must be checked when analysing a particular reproductive arrangement.